Denis Archambault

Professor
Denis
Archambault

Professor
University of Quebec at Montreal
Email 
archambault.denis [at] uqam.ca
Biography

I am a faculty member of the Department of Biological Sciences at the University of Québec at Montréal (UQAM) since 1991. I am specialized in RNA viruses (retroviruses, arteriviruses) and vaccine development. I hold DVM and PhD degrees from University of Montreal. I have completed postdoctoral studies at the National Institutes of Health (NIH) in Bethesda, Maryland (USA), and at the National Laboratory of Immunology in Ottawa (Canada) through fellowships from the Canadian Institutes of Health Research. Thereafter, I held a research scholarship from the Fonds de la Recherche en Santé du Québec from 1990 to 2002, while occupying my professor position at UQAM. I also have obtained a MBA degree from Sherbrooke University in 2001. In addition to my commitment in serving on grant review committees and as reviewer for various scientific journals, I have served on the editorial board of "Veterinary Research"​ from 1994 to 2009. I also have been appointed "Lead Guest Editor"​ for a special issue on "Arteriviruses" that appeared in March 2014 in the journal "BioMed Research International". I also served as "Guest Co- Editor" for the journal "Vaccines" on the topic "Vaccines and Antiviral Therapy against Respiratory Diseases" (2020-2022), and Guest Lead topic Editor for the journal "Frontiers in Immunology" on the topic "New-generation vaccines and novel vaccinal strategies against infectious diseases of livestock, wild and companion animals" (2022-2023).

Research interests

My current research interests involve studies in nanovaccine development and virus - host cell interactions. I also have interest in business and corporate development.

Discipline
Cellular biology Challenge study design Immunology – B-cells Immunology – T-cells Immunology – innate Molecular biology Virology
Host species
Cattle Pigs Poultry Zoonoses
Pathogen
Viruses VirusesCoronavirus VirusesInfluenza virus VirusesRetroviruses
Stage of vaccine development
Adjuvants Correlates of protection – immunomonitoring Vaccine delivery